new self tirzepatide F.D.A. Approves Obesity Drug That Will Compete With Wegovy Lilly releases Zepbound® (tirzepatide) single-dose

Diagnosis: Medical history and physical exam: To assess symptoms and identify risk factors

Eli Lilly alleged that Empower lured customers away from their brand-name GLP-1 products and toward the pharmacy's less-regulated version, interfering with its business and putting patients at risk.

Plantar fasciitis is a common source of foot pain in adults

Conclusion GLP1-RA therapy with liraglutide or semaglutide for 12 months is efficacious and safe for the treatment of weight regain following bariatric surgery

Sensitivity analyses were conducted to test the robustness of results across a range of assumptions

Experts explain how the drug works, where it came from, and what kinds of side effects to expect